OCUPATCH^TM

Ocupatch^TM is a transdermal drug delivery system for topical treatment of ophthalmic diseases. It is applied to the surface of upper or lower eyelid. The drug in the Ocupatch^TM is able to penetrate into the eyelid directly that results in more sustained effect than eye drops.

SENJU USA CLINICAL TRIALS

Senju USA has conducted Phase 3 clinical trial with the novel steroid patch.
Study Title:  Safety and efficacy study of SUN 131 TDS as compared to Placebo TDS in adults with a chalazion

More details here.

SENJU USA DEVELOPMENT

Senju USA is investigating a unique product in the field of dental to enter the niche markets of dental disease.